Operating Income (Loss) in USD of VACCINEX, INC. from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
VACCINEX, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2017 to Q4 2024.
  • VACCINEX, INC. Operating Income (Loss) for the quarter ending 31 Dec 2024 was -$3.39M, a 32.1% increase year-over-year.
  • VACCINEX, INC. Operating Income (Loss) for the twelve months ending 31 Dec 2024 was -$18.7M, a 18.1% increase year-over-year.
  • VACCINEX, INC. annual Operating Income (Loss) for 2024 was -$18.7M, a 18.1% increase from 2023.
  • VACCINEX, INC. annual Operating Income (Loss) for 2023 was -$22.9M, a 15% decline from 2022.
  • VACCINEX, INC. annual Operating Income (Loss) for 2022 was -$19.9M, a 11.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

VACCINEX, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$18.7M -$3.39M +$1.6M +32.1% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$20.3M -$4.55M +$1.28M +22% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 -$21.6M -$5.72M +$1.36M +19.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 -$23M -$5.07M -$88K -1.77% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$22.9M -$4.99M +$131K +2.56% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$23M -$5.83M -$1.04M -21.7% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$22M -$7.08M -$1.68M -31% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$20.3M -$4.99M -$392K -8.53% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$19.9M -$5.12M +$399K +7.23% 01 Oct 2022 31 Dec 2022 10-K/A 25 Apr 2024
Q3 2022 -$20.3M -$4.79M +$271K +5.35% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$20.6M -$5.4M +$268K +4.73% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$20.8M -$4.59M +$1.65M +26.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$22.5M -$5.52M +$571K +9.38% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$23.1M -$5.06M +$3.52M +41% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$26.6M -$5.67M +$831K +12.8% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$27.4M -$6.24M +$919K +12.8% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$28.3M -$6.09M +$250K +3.94% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$28.6M -$8.58M -$905K -11.8% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$27.7M -$6.5M +$2.36M +26.6% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$30M -$7.16M +$1.98M +21.7% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$32M -$6.34M +$2.22M +26% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$34.2M -$7.68M -$1.22M -19% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$33M -$8.86M -$2.3M -35.1% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$30.7M -$9.14M -$3.43M -60.1% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$27.3M -$8.56M 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2020
Q3 2018 -$6.45M -$1.12M -21% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$6.56M -$1.89M -40.5% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$5.71M 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q3 2017 -$5.33M 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 -$4.67M 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018

VACCINEX, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$18.7M +$4.15M +18.1% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$22.9M -$2.98M -15% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$19.9M +$2.58M +11.5% 01 Jan 2022 31 Dec 2022 10-K/A 25 Apr 2024
2021 -$22.5M +$5.84M +20.6% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$28.3M +$3.68M +11.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$32M -$4.73M -17.4% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$27.3M -$6.18M -29.3% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2020
2017 -$21.1M 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.